Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity (Q44225298)

1 December 2017

title

Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity (English)

1 reference

1 December 2017

1 reference

1

1 reference

1 December 2017

Dwaine F Emerich

2

1 reference

1 December 2017

Barry J Hoffer

series ordinal

3

1 reference

1 December 2017

Raymond T Bartus

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

956

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

211-220

1 reference

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporine-A enhances choline acetyltransferase immunoreactivity in the septal region of adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport (RMP-7).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cerebrovascular effects of the bradykinin analog RMP-7 in normal and irradiated dog brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

FK506 and the role of immunophilins in nerve regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Developmental cell death in dopaminergic neurons of the substantia nigra of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Parkinson's disease. Second of two parts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Bradykinin and its Gly6 analogue are substrates of cyclophilin: a fluorine-19 magnetization transfer study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Potential role of calcineurin for brain ischemia and traumatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporin A targets involved in protection against glutamate excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Neural actions of immunophilin ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Mitochondria in neurodegenerative apoptosis: an opportunity for therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Calcineurin as a possible new target for treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903474-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(02)03474-1

1 reference

1 December 2017

1 reference